结构:Cc1cc(=O)n(-c2ccccc2)[nH]1
HCID70335

1H-Pyrazol-5-ol, 3-methyl-1-phenyl-

5-methyl-2-phenyl-1H-pyrazol-3-one

C10H10N2O174.2 g/molCAS 19735-89-8

IDENTITY

结构与身份

标准 SMILES
Cc1cc(=O)n(-c2ccccc2)[nH]1
InChIKey
KZQYIMCESJLPQH-UHFFFAOYSA-N
分子式
C10H10N2O
平均分子量
174.2 g/mol
单同位素质量
174.07931295

COMPUTED

结构计算性质

已同步
XLogP
1.8
极性表面积
32.3 Ų
氢键供体
1
氢键受体
2
可旋转键
1
重原子
13
形式电荷
0
复杂度
241

PROPERTIES

实验与物化性质

来源:PubChem
Melting Point

130 °C

Physical Description

Solid

PHARMACOLOGY

药理信息

来源:PubChem
Metabolism/Metabolites

Edaravone has known human metabolites that include (2S,3S,4S,5R)-3,4,5-trihydroxy-6-(5-methyl-2-phenylpyrazol-3-yl)oxyoxane-2-carboxylic acid.;Norantipyrine is a known human metabolite of antipyrine.

Cellular Locations

Cytoplasm;Extracellular

USES

用途与制造

来源:PubChem
General Manufacturing Information

1H-Pyrazol-5-ol, 3-methyl-1-phenyl-: INACTIVE

ALIASES

名称与别名

76
3-Methyl-1-phenyl-1H-pyrazol-5-ol942-32-51H-Pyrazol-5-ol, 3-methyl-1-phenyl-EINECS 213-390-4DTXSID9061334RefChem:438923DTXCID504892419735-89-85-METHYL-2-PHENYL-1,2-DIHYDROPYRAZOL-3-ONE5-methyl-2-phenyl-1H-pyrazol-3(2H)-one5-Methyl-2-phenyl-2H-pyrazol-3-ol1,2-Dihydro-5-methyl-2-phenyl-3H-pyrazol-3-one5-methyl-2-phenyl-1H-pyrazol-3-oneN-Demethylantipyrine3H-Pyrazol-3-one, 1,2-dihydro-5-methyl-2-phenyl-5-methyl-2-phenyl-1,2-dihydro-3H-pyrazol-3-one5-hydroxy-3-methyl-1-phenylpyrazole3-Methyl-1-phenylpyrazolin-5-one5-methyl-2-phenyl-2,3-dihydro-1H-pyrazol-3-oneMFCD00127930

REACTIONS

参与反应

12